feed,title,long_url,short_url
SeekingAlpha,Editas Medicine up 13% following Q2 2022 top and bottom line beats as net loss narrows,https://seekingalpha.com/news/3865763,
SeekingAlpha,Seres rises 16% as co expects to file BLA for C. difficile infection treatment in coming weeks,https://seekingalpha.com/news/3865792,
